The commercial failure of Biogen Inc.’s drug Aduhelm is putting new focus on the state of research into the causes of Alzheimer’s disease.

More than six million people in the U.S. are living with the progressive type of dementia, according to the Alzheimer’s Association, an advocacy group.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Suspect charged in theft of Jackie Robinson statue that was found burned in Kansas

A suspect has been arrested in connection with the theft of a…

Jamie Foxx apologizes after ‘fake friends’ Instagram post is accused of being antisemitic

Actor Jamie Foxx apologized to the Jewish community Saturday after a cryptic…

What the Capitol riot suggests about the far right’s scary future post-Trump

The country watched in disbelief as far-right protesters stormed the U.S. Capitol…

Soldier, 23, dies during training incident in California, U.S. Army says

A 23-year-old soldier died Thursday during a training incident at the National…